Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutaz M Jaber

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|January 8, 2023
Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modelingMutaz M Jaber, Richard C Brundage
CPT: Pharmacometrics & Systems Pharmacology|May 5, 2021
Evaluation of bias in weighted residual calculations when handling below the limit of quantification data using Beal's M3 methodMutaz M Jaber, Shen Cheng, Richard C Brundage
Pharmaceutics|June 2, 2021
Application of Deep Neural Networks as a Prescreening Tool to Assign Individualized Absorption Models in Pharmacokinetic AnalysisMutaz M Jaber, Burhaneddin Yaman, Kyriakie Sarafoglou, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 22, 2020
Individualized Absorption Models in Population Pharmacokinetic AnalysesMutaz M Jaber, Mahmoud Al-Kofahi, Kyriakie Sarafoglou, et al.
Clinical Pharmacokinetics|July 6, 2023
Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative SimulationsTakuto Takahashi, Mutaz M Jaber, Sarah J Brown, et al.
European Journal of Endocrinology|October 26, 2020
Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasiaKyriakie Sarafoglou, Mutaz M Jaber, Mahmoud Al-Kofahi, et al.
Journal of Clinical Pharmacology|December 31, 2021
Predictive Value of C-Reactive Protein and Albumin for Temporal Within-Individual Pharmacokinetic Variability of Voriconazole in Pediatric Patients Undergoing Hematopoietic Cell TransplantationTakuto Takahashi, Mutaz M Jaber, Angela R Smith, et al.
Clinical Pharmacokinetics|June 7, 2023
Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic MalignancyTakuto Takahashi, Masahiro Teramoto, Kana Matsumoto, et al.
British Journal of Pharmacology|January 22, 2026
A model-based analysis of the CYP2C9 genotype effects on fluconazole inhibition using flurbiprofen, ketoprofen and tolbutamide as probe drugsShen Cheng, Darcy R Flora, Mutaz M Jaber, et al.
Journal of Clinical Pharmacology|September 5, 2022
Influence of Renal Function on Phosphoramide Mustard Exposure: A Nonlinear Mixed-Effects AnalysisMutaz M Jaber, Takuto Takahashi, Mark N Kirstein, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|January 8, 2023
Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modelingMutaz M Jaber, Richard C Brundage
CPT: Pharmacometrics & Systems Pharmacology|May 5, 2021
Evaluation of bias in weighted residual calculations when handling below the limit of quantification data using Beal's M3 methodMutaz M Jaber, Shen Cheng, Richard C Brundage
Pharmaceutics|June 2, 2021
Application of Deep Neural Networks as a Prescreening Tool to Assign Individualized Absorption Models in Pharmacokinetic AnalysisMutaz M Jaber, Burhaneddin Yaman, Kyriakie Sarafoglou, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 22, 2020
Individualized Absorption Models in Population Pharmacokinetic AnalysesMutaz M Jaber, Mahmoud Al-Kofahi, Kyriakie Sarafoglou, et al.
Clinical Pharmacokinetics|July 6, 2023
Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative SimulationsTakuto Takahashi, Mutaz M Jaber, Sarah J Brown, et al.
European Journal of Endocrinology|October 26, 2020
Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasiaKyriakie Sarafoglou, Mutaz M Jaber, Mahmoud Al-Kofahi, et al.
Journal of Clinical Pharmacology|December 31, 2021
Predictive Value of C-Reactive Protein and Albumin for Temporal Within-Individual Pharmacokinetic Variability of Voriconazole in Pediatric Patients Undergoing Hematopoietic Cell TransplantationTakuto Takahashi, Mutaz M Jaber, Angela R Smith, et al.
Clinical Pharmacokinetics|June 7, 2023
Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic MalignancyTakuto Takahashi, Masahiro Teramoto, Kana Matsumoto, et al.
British Journal of Pharmacology|January 22, 2026
A model-based analysis of the CYP2C9 genotype effects on fluconazole inhibition using flurbiprofen, ketoprofen and tolbutamide as probe drugsShen Cheng, Darcy R Flora, Mutaz M Jaber, et al.
Journal of Clinical Pharmacology|September 5, 2022
Influence of Renal Function on Phosphoramide Mustard Exposure: A Nonlinear Mixed-Effects AnalysisMutaz M Jaber, Takuto Takahashi, Mark N Kirstein, et al.
Pageof 2